Learning oncology studies - What is the difference between Solid Tumors and Carcinomas ?

 

癌症（cancer）是一种疾病，指的是几乎遍布体内的细胞开始不受控制地分裂。

当实体组织（如：器官、肌肉或骨骼）里出现癌细胞增长时，我们称之为肿瘤（tumor），后者或可从血液及淋巴系统扩散到周围的组织中。

癌症治疗旨在消除这些异常细胞，或减缓、阻止癌细胞扩散。

实体肿瘤（solid tumors）被分为两大类：恶性（malignant，具有致癌性）肿瘤和良性（benign，不具有致癌性）肿瘤。

具有致癌性的肿瘤可以侵入到身体内周围的组织中，且随着这些肿瘤的生长，有些癌细胞或许还会游离到身体的其它部位，以形成其它的 “继发性” 肿瘤（ “secondary” tumors），我们也把后者称为转移（瘤）（metastases）。


实体恶性肿瘤的例子包括癌（carcinomas）和肉瘤（sarcomas）。


1.癌（carcinomas）指的是在细胞内生成的癌症，这些细胞是组织内层器官（tissue lining organs）的组成，如：肝脏（liver）或肾脏（kidney）。


2.肉瘤（sarcomas）则是指身体结缔组织（connective tissues）中形成的癌症，例如：在肌肉、骨骼和神经中的癌症。


摘抄自：

https://www.dana-farber.org/for-patients-and-families/becoming-a-patient/international-patients/chinese/inspiration/%E7%99%8C%E7%97%87%E5%92%8C%E8%82%BF%E7%98%A4%E7%9A%84%E5%8C%BA%E5%88%ABcancer-and-a-tumor/


Comments

Post a Comment

Popular posts from this blog

Analysis of Repeated Measures Data using SAS (1)

Image
 1. Basic Concepts of Repeated Measures: In this basic setup of a completely randomized design with repeated measures, there are two factors, treatments and time. Treatment is called the between-subjects factor because levels of treatment can change only between subjects; all measurements on the same subject will represent the same treatment. Time is called a within-subjects factor because different measurements on the same subject are taken at different times.  In repeated measures experiments, interest centers on (1) how treatment means differ, (2) how treatment means change over time, and (3) how differences between treatment means change over time. 2. Four-step procedure for mixed model analysis: Step 1: Model the mean structure, usually by specification of the fixed effects. Step 2: Specify the covariance structure, between subjects as well as within subjects. Step 3: Fit the mean model accounting for the covariance structure. Step 4: Make statistical inference bas...
Read more

Understanding Binding vs. Non-Binding Futility Analysis in Clinical Trials

Image
  1.What is the difference between binding futility and non-binding futility analysis ? In clinical trials,   futility analysis   is a type of interim analysis used to determine whether it is unlikely that a study will achieve its objectives if it continues as planned. This helps avoid wasting resources and exposing participants to ineffective treatments. Futility analyses can be   binding   or   non-binding , and the distinction is important for trial design and interpretation. 🔹 Binding Futility Analysis Definition : If the futility boundary is crossed, the trial  must be stopped . Implication : It is part of the formal decision-making process and is enforced by the protocol or statistical analysis plan. Use Case : Often used when ethical or resource concerns demand early termination if the treatment is clearly not effective. 🔹 Non-Binding Futility Analysis Definition : If the futility boundary is crossed, the trial  may continue ...
Read more

Medical information for Melanoma, Merkel cell carcinoma and tumor mutation burden

  Background: Melanoma Also called: malignant melanoma The most serious type of skin cancer. Melanoma occurs when the pigment-producing cells that give color to the skin become cancerous. Symptoms might include a new, unusual growth or a change in an existing mole. Melanomas can occur anywhere on the body. Treatment may involve surgery, radiation, medications, or in some cases chemotherapy. Merkel cell carcinoma  (MCC) it is a very rare ,  highly aggressive, neuroendocrine carcinoma of the skin ;  it has a worse survival probability compared with more common cutaneous malignancies, including metastatic melanoma, and has been termed the “most lethal” skin cancer  as   p atients with metastatic MCC have a historical 5-year overall survival (OS) rate of 18% What Is Tumor Mutational Burden? TMB is defined as the frequency of certain mutations within a tumor’s genes.  To be counted towards TMB, mutations have to alter the protein that is made from a gene. ...
Read more